Viloxazine hydrochloride is a selective norepinephrine reuptake inhibitor mainly indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It is marketed under the brand name Qelbree in the United States and was previously used in Europe as an antidepressant before being discontinued and later repurposed for ADHD. Its therapeutic use is listed as ADHD agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Vivalan and Vicilan. Its PubChem CID is 71424.
Viloxazine hydrochloride
| CAS No | 35604-67-2 |
|---|---|
| Molecular Formula | C13H20ClNO3 |
| Molecular Weight | 273.75 g/mol |
| Synonyms | 2-[(2-ethoxyphenoxy)methyl]morpholine;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Viloxazine hydrochloride is a selective norepinephrine reuptake inhibitor mainly indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults.
The listed CAS number is 35604-67-2.
The listed molecular formula is C13H20ClNO3.
The listed molecular weight is 273.75 g/mol.
2-[(2-ethoxyphenoxy)methyl]morpholine;hydrochloride.
The source lists Vivalan and Vicilan.